Streetwise Company Fact Sheet2025/3/9 15:31:27
(SVA:TSX.V - SEOVF:OTCQB - PSH:XETRA)
Analyst coverage
| Rodman & Renshaw — Dr. Tony Butler |
| Raymond James — Michael Freeman |
| Leede Financial Inc. — Dr. Douglas Loe |
| Leede Jones Gable — Doug Loe |
| H.C. Wainwright & Co. — Dr. Joseph Pantginis |
| Echelon Capital Markets — Stefan Quenneville |
| Raymond James — Rahul Sarugaser |
| Research Capital Corporation — Dr. Andre Uddin |
Newsletter coverage
| — |
| — |
Company News
| View Latest News |
Streetwise Reports Articles
| 03/06/2025 - View Article |
| 02/06/2025 - View Article |
| 02/06/2025 - View Article |
| 02/04/2025 - View Article |
| 12/03/2024 - View Article |
Streetwise - Sernova Biotherapeutics Inc. Ownership Overview*
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA)
*Share Structure as of 1/31/2025
Company News
3/3/2025 – Sernova Biotherapeutics Receives FDA Clearance for IND Application for its Cell Pouch Bio-hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
2/3/2025 – Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
12/20/2024 – Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
